Veterinary News and Research

RSS

Studies detect integrons that cause resistance to various antibiotics

In Mexico the sale of antibiotics for human consumption is controlled to prevent misuse, although in the veterinary sector failure in the implementation of the Official Mexican Standard NOM-064-ZOO-2000, "Guidelines for veterinarian products prescription", has prompted common bacteria such as Escherichia coli and Salmonella spp to become resistant to regular drugs such as streptomycin, trimethoprim, ampicillin, gentamicin, and tetracycline as a result of excess drug use.

12 Aug 2014

Scientists examine mechanisms that cause ageing in tendons of horses

University of Liverpool scientists have examined the mechanisms that cause ageing in the tendons of horses, opening up the possibility of better treatment for humans.

6 Aug 2014

New clinical trial tests use of gold nanoparticles for treating solid tumors in dogs and cats

When Michael and Sandra Friedlander first came to the Virginia-Maryland College of Veterinary Medicine three years ago with their dog, Grayton, they learned some bad news: Grayton had nasal adenocarcinoma, a form of cancer with a short life expectancy.

5 Aug 2014

Henry Schein net sales increase 9.3% to $2.6 billion in Q2 2014

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended June 28, 2014.

4 Aug 2014

Mice lacking specific protein live longer lives with fewer age-related illnesses

While developing a new cancer drug, researchers at The Wistar Institute discovered that mice lacking a specific protein live longer lives with fewer age-related illnesses.

31 Jul 2014

Researchers establish new strategy to help surgeons see entire tumor in patient

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

30 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

Researchers identify porcine enterovirus G using next-generation sequencing

He calls himself the bug hunter, but the target of his work consists of viruses that can only be found and identified with special methods and instruments.

29 Jul 2014

Xybion to host first annual Global User Group Conference in Philadelphia, Pennsylvania

Xybion Corporation, the leading provider of software, services and consulting for global corporations operating in highly regulated industries, announced today that the company will host its first annual Global User Group Conference, Xybion International Exchange, on October 21-23, 2014 in historic Philadelphia, Pennsylvania at the Sheraton Society Hill Hotel.

26 Jul 2014

IDEXX revenues increase 11% to $390M in second quarter 2014

IDEXX Laboratories, Inc. today reported that revenues for the second quarter of 2014 increased 11% versus the prior year period to $390 million.

25 Jul 2014

Mexico, US sign statement of intent to promote safety of fresh agricultural products

The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.

25 Jul 2014

FDA approves Targiniq ER to treat severe pain

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

24 Jul 2014

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.

24 Jul 2014

Randox expands major supplier agreement with Novation

Randox Laboratories has further expanded its market presence in the United States, having been awarded a major supplier agreement with Novation, the leading health care supply chain expertise, analytics and contracting company.

From Randox Laboratories Ltd. 22 Jul 2014

RX daytona+ provides high quality testing on compact easy to use platform

Randox has developed a versatile range of clinical chemistry analyzers with real cost saving in mind. The RX series of clinical chemistry analyzers provides performance like no other.

From Randox Laboratories Ltd. 22 Jul 2014

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company's Acusera Immunoassay Speciality 1 quality control for use in US laboratories.

From Randox Laboratories Ltd. 22 Jul 2014

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

The U.S. Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).

18 Jul 2014

Eating lean beef can reduce risk factors for heart disease

Contrary to conventional wisdom, a growing body of evidence shows that eating lean beef can reduce risk factors for heart disease, according to recent research by nutritional scientists.

18 Jul 2014

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim’s nintedanib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).

17 Jul 2014

Research shows promise to speed up drug discovery for deadly diseases

Antibiotic resistance is depleting our arsenal against deadly diseases and infections, such as tuberculosis and Staph infections, but recent research shows promise to speed up the drug discovery process.

16 Jul 2014

Veterinary News and Research

Studies detect integrons that cause resistance to various antibiotics

Scientists examine mechanisms that cause ageing in tendons of horses

New clinical trial tests use of gold nanoparticles for treating solid tumors in dogs and cats

Henry Schein net sales increase 9.3% to $2.6 billion in Q2 2014

Mice lacking specific protein live longer lives with fewer age-related illnesses

Researchers establish new strategy to help surgeons see entire tumor in patient

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Researchers identify porcine enterovirus G using next-generation sequencing

Xybion to host first annual Global User Group Conference in Philadelphia, Pennsylvania

IDEXX revenues increase 11% to $390M in second quarter 2014

Mexico, US sign statement of intent to promote safety of fresh agricultural products

FDA approves Targiniq ER to treat severe pain

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Randox expands major supplier agreement with Novation

RX daytona+ provides high quality testing on compact easy to use platform

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

Eating lean beef can reduce risk factors for heart disease

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim’s nintedanib

Research shows promise to speed up drug discovery for deadly diseases

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News